IOVANCE BIOTHERAPEUTICS INC (IOVA)
US4622601007 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 134.19M | 114.89M | 231.70M | 78.20M | 67.30M | |||
| Marketable Securities | 222.01M | 164.98M | 240.10M | 426.20M | 562.10M | |||
| Receivables | 234.00K | 151.00K | N/A | N/A | N/A | |||
| Inventories | 17.62M | 10.37M | N/A | N/A | N/A | |||
| Other Current Assets | 11.49M | 17.46M | 7.30M | 3.50M | 6.70M | |||
| Total Current Assets | 385.53M | 307.85M | 479.10M | 508.00M | 636.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 183.31M | 176.54M | 178.20M | 169.90M | 113.90M | |||
| Investments And Advances | N/A | N/A | 0.00 | 91.60M | N/A | |||
| Intangibles | 294.30M | 229.26M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 6.69M | 66.70M | 6.60M | 7.90M | 18.40M | |||
| Total Non-Current Assets | 484.30M | 472.50M | 184.90M | 269.30M | 132.40M | |||
| TOTAL ASSETS | 869.83M | 780.35M | 664.00M | 777.30M | 768.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 57.51M | 77.18M | 64.90M | 61.80M | 41.40M | |||
| Accounts Payable | 25.70M | 33.12M | 26.60M | 27.40M | 13.50M | |||
| Total Current Liabilities | 83.21M | 110.31M | 91.50M | 89.20M | 54.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.00M | 1.00M | 1.00M | 1.00M | 0.00 | |||
| Deferred Taxes/Income | 33.30M | 17.35M | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 72.29M | 67.08M | 71.90M | 65.50M | 57.10M | |||
| Total Non-Current Liabilities | 106.59M | 85.43M | 72.80M | 66.50M | 57.10M | |||
| TOTAL LIABILITIES | 189.81M | 195.74M | 164.30M | 155.70M | 112.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.13B | -2.01B | -1.57B | -1.17B | -830.20M | |||
| Additional Paid In Capital | 2.81B | 2.59B | 2.07B | 1.79B | 1.49B | |||
| Common Shares | 15.00K | 14.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 116.00K | 2.53M | -900.00K | -600.00K | 0.00 | |||
| Shares Outstanding | 279.76M | 256.14M | 187.80M | 157.00M | 146.90M | |||
| Tangible Book Value per Share | 1.38 | 1.39 | 2.66 | 3.96 | 4.47 | |||
| Total Shareholders' Equity | 680.02M | 584.61M | 499.60M | 621.70M | 656.50M | |||
| TOTAL LIABILITIES AND EQUITY | 869.83M | 780.35M | 664.00M | 777.30M | 768.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Current Ratio | 4.63 | 2.79 | 5.24 | 5.70 | 11.59 | |||
| Return On Assets (ROA) | -51.69% | -56.90% | -59.62% | -44.03% | -33.78% | |||
| Return On Equity (ROE) | -66.12% | -75.95% | -79.24% | -55.05% | -39.54% | |||
All data in USD